about
Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian CancerThe prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.A microRNA survival signature (MiSS) for advanced ovarian cancer.Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.Lymphopenia and its association with survival in patients with locally advanced cervical cancer.Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.Laparoscopy in the morbidly obese: physiologic considerations and surgical techniques to optimize success.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis.Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer.The Use of "Optimal Cytoreduction" Nomenclature in Ovarian Cancer Literature: Can We Move Toward a More Optimal Classification System?Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complicationsPerioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer.Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer.Disparities in Surgical Care Among Women With Endometrial Cancer.Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity.Feasibility of Robotic-Assisted Laparoendoscopic Single-Site Surgery in the Gynecologic Oncology Setting.Correlation of extreme drug resistant assay results and progression-free survival following intraperitoneal chemotherapy for advanced ovarian cancer.Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.Surgical care of young women diagnosed with ovarian cancer: a population-based perspective.Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky?Management of uterine adenosarcomas with and without sarcomatous overgrowth.A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model.Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.Warm-Up Before Robotic Hysterectomy Does Not Improve Trainee Operative Performance: A Randomized Trial.A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.Single site robotic sentinel lymph node biopsy and hysterectomy in endometrial cancer.
P50
Q26744528-15ADD1D0-8349-4A0A-95B2-63A6AC6D92DAQ30405874-AAD50C4F-15FA-41E2-83B9-D85E324044A4Q34167137-8D8537B1-A871-41BA-80B4-C9825CA66E16Q35533363-375D0B63-ECE9-482F-BBC9-70C1DE687B1DQ36663622-A6FC1CF0-C551-4F77-AF0F-7DFB526B6B55Q36796557-11916169-F939-43BF-A781-1632A7F82D46Q37540704-74916670-0158-4D9D-8018-CF9BD2C04810Q37938361-94A51C44-27AE-429C-A709-46F8C83C260FQ38150040-3F9A1EDE-208F-4DD8-834D-7ADC91084E73Q38243089-9D61D0B1-C276-41D1-BAEC-42BA0748F46AQ38733446-7B377A78-EE8E-4497-B036-1AF281E8439CQ38861948-B08AA2C8-66A5-445F-AD91-C037D7C1E146Q38928216-15D3F17D-1E97-4AA2-8CC2-EDF2CBF54101Q38941020-E8F615B5-1967-4CFA-8447-48AE3BFDDA64Q39015875-7A554FE9-F11A-470C-80B3-A760A5DC447DQ39052096-AD888350-25B4-4BA3-8E99-E94024F995C1Q39059860-EEF53BDF-C372-42EE-A344-4BD19C25F294Q39342232-FE34331F-5E18-426F-8762-AAE9711BE5EBQ39446539-BF288B01-05DA-4490-849B-20A4890A6710Q39513846-64D5084B-1B96-49D0-9CBC-404D98A96B86Q40051200-B1F5D98D-8E35-4F3C-B35E-277DBD20A7DAQ40233434-0B60C6F8-A21F-48A4-9D81-912AE3F8A6DFQ40488896-8C489708-C645-4B0E-8841-07619035C5BCQ42946330-BBF123D4-E53D-4892-A690-B7A752AABB09Q43163408-9C2075B5-9258-42AC-8F50-BBCC8E61E44EQ43435555-AC73B08C-58C9-46C1-8D70-DA5CD2EE9E5BQ44008957-F57206BB-1ED9-40F6-8F4D-9BE463A0CA6AQ44478986-1A380E10-69E3-49BB-8FE4-F638834F9F74Q44982977-BF3A34DB-87D6-4B70-A0DF-F34DADFDE0B4Q45367726-B5840A10-527C-467D-8979-8152CFFF9508Q46061540-4D66B774-7A2E-426A-A1A7-4E03E7881A5FQ46686030-98DD4EA8-CFD2-4DB2-BA48-49CC9009CB77Q47101896-9BE85FC3-090A-4971-BF5F-6FC24E30038DQ47337319-DC6F609E-F68C-4979-8AE0-8E8FFBBE0FFFQ47430381-9F17347D-61F2-4109-9851-DE8D7C57178FQ47637338-77FBE55A-3B55-4680-BB5B-7C5DB813754EQ50212857-666EFC11-5D3B-410A-B44C-CD27A1B8166CQ50219029-9BCBFBFA-C1B4-41F3-8CC6-F25A894672F4Q50426784-21B075DC-AFAF-4A11-9760-54C407110E3EQ50958671-8FF74971-CE37-4AFC-A553-A06477D43FB2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Edward J Tanner
@ast
Edward J Tanner
@en
Edward J Tanner
@es
Edward J Tanner
@nl
Edward J Tanner
@sl
type
label
Edward J Tanner
@ast
Edward J Tanner
@en
Edward J Tanner
@es
Edward J Tanner
@nl
Edward J Tanner
@sl
prefLabel
Edward J Tanner
@ast
Edward J Tanner
@en
Edward J Tanner
@es
Edward J Tanner
@nl
Edward J Tanner
@sl
P106
P21
P31
P496
0000-0003-0829-1642